Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
In First Real-World Study, Pfizer Vaccine Shows High Rate of Effectiveness in Israel
Error: Contact form not found.
by JNS.org
Trial kits for Pfizer’s coronavirus disease (COVID-19) vaccination study are seen at the Research Centers of America, in Hollywood, Florida, Sept. 24, 2020. Photo: Reuters / Marco Bello.
JNS.org – Data released by Israel’s Ministry of Health and one of its top healthcare providers indicate that the COVID-19 vaccine from Pfizer is proving to be highly effective in providing immunity from the virus.
According to the Ministry of Health, a total of 317 out of 715,425 Israelis who were fully vaccinated (at least a week after receiving both doses) contracted the virus, with only just 16 coming down with serious cases in need of hospitalization.
At the same time, Maccabi Healthcare Services—one of the four health providers in Israel—reported that only 31 out of the 163,000 Israelis vaccinated by them caught the coronavirus after 10 days of receiving the second dose, which is when full immunity is expected.
In the control group of unvaccinated Israelis during the same period, some 6,437 were diagnosed with COVID-19.
“This is very, very good news,” Anat Ekka Zohar, Maccabi’s top vaccine statistics analyst, told The Times of Israel. “It is the first study in the world that looks at such a large number of fully vaccinated patients.”
The data from Israel is the first real-world look into the effectiveness of the coronavirus vaccine. Israel has been one of the leading countries in vaccinations per capita.
During its clinical trials, Pfizer achieved 95 percent efficacy, and medical professionals from around the world had been looking to Israel to see the results of the vaccine so far.
